BIOLUnknown
BIOLASE, INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for BIOLASE, INC (BIOL), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are BIOL insiders buying or selling?
BIOLASE, INC insiders reported no open-market purchases or sales in the last 12 months. Since August 2018, Trabud has recorded 18 Form 4 filings for BIOL: 12 buys ($1.3M) and 6 sells ($8.5M).
Source: SEC EDGAR Form 4
Key Statistics (August 2018 – May 26, 2023)
Total Form 4 filings
18
SEC EDGAR
Insider filers
7
Insider buys (12)
$1.3M
Insider sells (6)
$8.5M
Insider sentiment
Net sellingNet insider flow of $7.2M in net selling since August 2018.
Recent BIOL insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2023 | Schuler Education Foundation | 10% Owner | Sale | 7.9M | $0.43 | $3.3M | SEC ↗ |
| Dec 9, 2022 | Jonathan T Lord MD | Director | Sale | 3.5K | $0.75 | $2.7K | SEC ↗ |
| Dec 16, 2021 | Jonathan T Lord MD | Director | Sale | 11.0K | $0.38 | $4.2K | SEC ↗ |
| Dec 2, 2021 | John R Beaver | President & CEO | Purchase | 70.0K | $0.45 | $31.5K | SEC ↗ |
| Aug 23, 2021 | John R Beaver | President & CEO | Purchase | 35.0K | $0.61 | $21.4K | SEC ↗ |
| May 19, 2021 | John R Beaver | President & CEO | Purchase | 40.0K | $0.75 | $30.0K | SEC ↗ |
| Jun 10, 2020 | FEINBERG LARRY N | 10% Owner | Sale | 5.2M | $0.55 | $2.9M | SEC ↗ |
| May 15, 2020 | Jack W Schuler | 10% Owner | Sale | 1.3M | $0.60 | $784.8K | SEC ↗ |
| Nov 1, 2019 | FEINBERG LARRY N | 10% Owner | Purchase | 17.4K | $57.50 | $1000.0K | SEC ↗ |
| Jun 27, 2019 | FEINBERG LARRY N | 10% Owner | Sale | 1.0M | $1.50 | $1.5M | SEC ↗ |
| Dec 15, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.07 | $5.3K | SEC ↗ |
| Dec 15, 2018 | Todd Norbe | President and CEO | Purchase | 15.0K | $1.03 | $15.5K | SEC ↗ |
| Dec 6, 2018 | John R Beaver | EVP & Chief Financial Officer | Purchase | 1.0K | $1.18 | $1.2K | SEC ↗ |
| Nov 30, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.22 | $6.1K | SEC ↗ |
| Nov 21, 2018 | Jonathan T Lord MD | Director | Purchase | 10.0K | $1.36 | $13.6K | SEC ↗ |
| Aug 17, 2018 | John R Beaver | EVP & Chief Financial Officer | Purchase | 25.0K | $1.67 | $41.8K | SEC ↗ |
| Aug 14, 2018 | Jonathan T Lord MD | Director | Purchase | 100.0K | $1.31 | $131.1K | SEC ↗ |
| Aug 14, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.37 | $6.8K | SEC ↗ |
Showing the 18 most recent of 18 Form 4 filings for BIOLASE, INC.
Most active BIOL insiders
- John R Beaver5 filings
- Jonathan T Lord MD4 filings
- FEINBERG LARRY N3 filings
- Garrett Sato3 filings
- Jack W Schuler1 filing
Ask anything about BIOL insider activity
Use Trabud's AI agent to query BIOLASE, INC's Form 4 history in plain English — "Show me BIOL CEO purchases this year" or compare it against any other ticker.
Open the AI agentBIOL insider trading FAQ
Are BIOLASE, INC insiders buying or selling?
BIOLASE, INC insiders reported no open-market purchases or sales in the last 12 months. Since August 2018, Trabud has recorded 18 Form 4 filings for BIOL: 12 buys ($1.3M) and 6 sells ($8.5M). Over the full record that is net selling of $7.2M.
How many insiders trade BIOL stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BIOLASE, INC. The most recent filing was accepted on May 26, 2023.
Where does Trabud get BIOL insider trading data?
All BIOL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.